Nurse Practitioner · Adrian, MI
NPI
1689863391
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
777 Kimole Ln, Ste. 260
Adrian, MI, 49221
Phone (517) 265-4770
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
1,261 services
Medicare patients, 2024
368
Average age 76
Drug cost, 2024
$220K
2,677 prescriptions
Company payments, 2025
$107
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anne E Butts was code 99213 (office e&m - established), 430 times for 325 patients. In total Anne E Butts billed 1,261 services in 20 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 430 | 325 | $50.30 | $22K |
| 81002 Clinical Chemistry | Office | 264 | 203 | $3.39 | $894 |
| 51798 Ultrasound - Nonspecific | Office | 137 | 110 | $7.26 | $995 |
| 99214 Office E&M - Established | Office | 69 | 65 | $76.00 | $5,244 |
| 99203 Office E&M - New | Office | 11 | 11 | $42.94 | $472 |
By year: 2022 $35K for 1,554 services; 2023 $41K for 1,276 services; 2024 $37K for 1,261 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 264 | 203 | $3.39 | $894 |
Medicare prescription drug claims, 2024
In 2024, the drug Anne E Butts prescribed most often to Medicare patients was Tamsulosin Hcl, with 698 prescriptions and refills. In total Anne E Butts wrote 2,677 Medicare prescriptions that cost $220K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 698 | 1,788 | 192 | $12K |
| Finasteride Generic | 584 | 1,584 | 159 | $11K |
| Solifenacin Succinate Generic | 158 | 345 | 48 | $8,759 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 133 | 339 | 38 | $4,233 |
| Myrbetriq Mirabegron | 132 | 231 | 34 | $113K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 109 | 286 | 36 | $2,882 |
| Cephalexin Generic | 104 | 126 | 68 | $620 |
| Oxybutynin Chloride Generic | 101 | 251 | 31 | $1,494 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 74 | 104 | 39 | $1,440 |
| Ciprofloxacin Hcl Generic | 55 | 55 | 44 | $189 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 54 | 142 | 16 | $4,989 |
| Bicalutamide Generic | 45 | 135 | 15 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 54 | 32 | $144 |
| Mirabegron Er Mirabegron | 28 | 64 | Under 11 | $23K |
| Estradiol Generic | 27 | 47 | 16 | $1,575 |
Brand drugs: 186 claims; generic drugs: 2,491 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anne E Butts $107 ($107 in general payments such as food, travel and fees) from 5 companies. The largest payer was Progenics Pharmaceuticals, Inc. with $26.21.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.